Oscar Health (OSCR) EBIT Margin (2020 - 2026)

Oscar Health has reported EBIT Margin for 7 years, with the latest figure at 1060.06% in Q1 2026.

• For the quarter ending Q1 2026, EBIT Margin fell 580191.0% year-over-year to 1060.06%; the trailing twelve-month figure through Mar 2026 stood at 1.14% (down 905.0% YoY), and the FY2025 full-year result was 3.39%, down 541.0% from the prior year.
• EBIT Margin for Q1 2026 stood at 1060.06%, up from 2.86% in the prior quarter.
• The five-year high for EBIT Margin was 6861.96% in Q1 2025, with the low at 22.69% in Q4 2023.
• Historically, EBIT Margin has averaged 559.61% across 5 years, with a median of 1.89% in 2025.
• Annual changes were most pronounced in 2025 — EBIT Margin jumped 685991 bps — and 2026, when it sank 580191 bps.
• Oscar Health's EBIT Margin stood at 22.36% in 2022, then retreated by 1 bps to 22.69% in 2023, then soared by 97 bps to 0.76% in 2024, then sank by 278 bps to 2.86% in 2025, then surged by 37204 bps to 1060.06% in 2026.
• The last three EBIT Margin figures came in at 1060.06% (Q1 2026), 2.86% (Q4 2025), and 604.65% (Q3 2025), per Business Quant data.